Gonul, ZeynepOzturk, Dilara AltayKucukbay, FatumetuzzehraTekin, SuatTekin, ZehraKucukbay, Hasan2024-08-042024-08-0420230022-152X1943-5193https://doi.org/10.1002/jhet.4564https://hdl.handle.net/11616/100879In this study, 10 new indole-dipeptide conjugates were synthesized, and their anticancer activity was determined against on A2780 (ovarian cancer cell line) and MCF-7 (breast cancer cell line) cells. Among compounds, 5 and 10 showed better activity against A2780 cell lines than the standard drug docatexel at 0.1 and 1 mu M concentrations, while only compound 5 showed better activity than docatexel, the MCF-7 cell line at 0.1 and 1 mu M concentrations. The antioxidant potencies of the compounds were low in both the DPPH and iron reducing power methods tested when compared to standard antioxidants used in this work.eninfo:eu-repo/semantics/closedAccessRapid Colorimetric AssayAnticancer AgentsVinblastineSurvivalScaffoldGrowthArticle601869510.1002/jhet.45642-s2.0-85137595024Q3WOS:000849881000001Q2